Simeng Zhang
Shenyang, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
PD-1 inhibitors combined with paclitaxel and cisplatin in first-line treatment of esophageal squamous cell carcinoma (ESCC): a network meta-analysis.
Journal: BMC cancer
Published: August 26, 2023
Platelet-derived microparticles and their cargos: The past, present and future.
Journal: Asian journal of pharmaceutical sciences
Published: July 05, 2023
BRAF L485-P490 deletion mutant metastatic melanoma sensitive to BRAF and MEK inhibition: A case report and literature review.
Journal: Frontiers in pharmacology
Published: August 14, 2022
TMEM92 acts as an immune-resistance and prognostic marker in pancreatic cancer from the perspective of predictive, preventive, and personalized medicine.
Journal: The EPMA journal
Published: April 29, 2022
Complete Pathologic Response of Multiple Liver Metastases and Clinical Complete Response of Rectal Cancer in a Patient with Ataxia-Telangiectasia Mutated Gene Mutations After XELOXIRI Plus Bevacizumab: A Case Report.
Journal: OncoTargets and therapy
Published: May 18, 2021
Could Camrelizumab Plus Chemotherapy Improve Clinical Outcomes in Advanced Malignancy? A Systematic Review and Network Meta-Analysis.
Journal: Frontiers in oncology
Published: April 25, 2021
NR2F1-AS1/miR-190a/PHLDB2 Induces the Epithelial-Mesenchymal Transformation Process in Gastric Cancer by Promoting Phosphorylation of AKT3.
Journal: Frontiers in cell and developmental biology
Published: March 31, 2021
PolG Inhibits Gastric Cancer Glycolysis and Viability by Suppressing PKM2 Phosphorylation.
Journal: Cancer management and research
Published: November 16, 2020
Clinical outcomes of capecitabine-based versus S-1-based regimens as first-line chemotherapy in patients with unresectable or metastatic gastric cancer: a propensity score matched single-center comparison.
Journal: Journal of gastrointestinal oncology
Published: September 21, 2020
Positive Cross-Talk Between CXC Chemokine Receptor 4 (CXCR4) and Epidermal Growth Factor Receptor (EGFR) Promotes Gastric Cancer Metastasis via the Nuclear Factor kappa B (NF-kB)-Dependent Pathway.
Journal: Medical science monitor : international medical journal of experimental and clinical research
Published: September 04, 2020
Nomogram-based prediction of survival in unresectable or metastatic gastric cancer patients with good performance status who received first-line chemotherapy.
Journal: Annals of translational medicine
Published: May 02, 2020
Last Updated: 09/26/2026